Serena Capelli1, Anna Caroli1, Giulio Pezzetti2, Francesca Ferretti3, Paola Cinque4, and Simonetta Gerevini2
1Bioengineering Department, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Ranica (BG), Italy, 2Department of Neuroradiology, ASST Papa Giovanni XXIII, Bergamo, Italy, 3Lewisham and Greenwich NHS trust, London, United Kingdom, 4Unit of Infectious Diseases, San Raffaele Scientific Institute, Milano, Italy
Synopsis
Keywords: Infectious disease, Infectious disease, HIV
This
study aimed at quantitatively assessing T1-weighted, FLAIR and DWI brain
alterations in 14 patients with cerebrospinal fluid HIV escape (HIV-ESC) and 7 patients
with untreated HIV encephalitis (HIV-ENC), versus 11 HIV patients without
neurological problems and 12 HIV-negative controls.
HIV-ESC
and HIV-ENC patients showed significantly higher ADC in WM and GM and increased
WM FLAIR signal than the other groups. In HIV-ESC patients, the heterogeneous GM
volume was negatively correlated with MRI time from infection.
WM
FLAIR hyperintensity in HIV-ESC and HIV-ENC patients may reflect vasogenic
edema, with mass effect depending on its degree and possible underlying brain atrophy.
Introduction
Despite contemporary systemic combined antiretroviral therapy (cART) being highly
successful in controlling HIV replication in the central nervous system (CNS),
some cases of HIV persistence in CNS have been increasingly observed.
Symptomatic
cerebrospinal fluid (CSF) HIV escape is defined as the detection of HIV-RNA in
CSF overcoming the replication in plasma in patients complaining of new onset
neurological problems, despite cART.1
Clinical and MRI
presentation resemble HIV encephalitis in untreated AIDS presenters, with
progressing neurological impairment and cognitive deterioration. Typical MRI
findings are white matter abnormalities, mainly consisting of hyperintense
signal alterations in T2 and FLAIR sequences.2
The aim of this study was
to quantitatively assess MR brain alterations in HIV CSF Escape (HIV-ESC) and
cART-untreated HIV encephalitis (HIV-ENC), as compared with treated HIV-positive
patients with no neurological problems (HIV) and HIV-negative controls (CTRL).Methods
Brain MRI scans from
14 patients with HIV-ESC (49[43-54] years, 64% males), 7 patients with HIV-ENC
(48[46-50] years, 100% males), 11 HIV-positive patients with no neurological
problems (50[44-59] years, 82% males) and 12 HIV-negative controls (39[29-46]
years, 75% males) were retrospectively analysed.
Brain MRI protocol included axial T1, FLAIR
and diffusion weighted imaging (DWI). All scans were processed by in-house semi-automatic
procedures embedding segmentation of grey matter (GM), white matter (WM) and
cerebrospinal fluid (CSF) on T1-weighted images, computation of brain tissues binary
masks, DWI motion correction and DWI coregistration to T1.
The Apparent Diffusion
Coefficient (ADC) was fitted voxel-wise using a mono-exponential equation, and
the resulting ADC maps were restricted to GM, WM, and CSF by using pertinent binary
masks.
The FLAIR scans were
intensity normalized using the whole GM as an internal reference. The average
GM intensity of the FLAIR signal (m) was calculated, and 1000/m was chosen as
the global modulating factor and applied to the raw image values for intensity
normalization.3
The volume of whole
brain, WM, GM, and CSF was computed based on the binary tissues masks resulting
from T1-weighted scan segmentation, after possible manual editing to correct
for inaccuracies.Results
There was no
statistically significant difference in the volumes of whole brain and
individual brain tissues among the groups studied; however, the volume of GM in
the HIV-ESC showed much larger dispersion than the other groups (Figure 2). A
significant negative correlation (Spearman ρ = -0.73, p = 0.007) between GM
volume and time from HIV infection to MRI was found in the HIV-ESC patient
group.
The median FLAIR
signal intensity was significantly higher in the WM of HIV-ESC and HIV-ENC
patients, than in the other two groups (Figure 3); no differences were found in
GM and CSF.
Both HIV-ESC and
HIV-ENC patients showed significantly higher ADC values as compared with HIV
and CTRL, in the whole brain, in GM and in WM (Figure 4). No statistically
significant differences were found in CSF among the four groups. The HIV-ESC
and HIV-ENC patient groups did not differ significantly from each other in any
of the brain tissues, and neither did the HIV from the CTRL group.Discussion
At onset of CSF escape,
WM hyperintensity can involve both supra and infra tentorial regions (periventricular
(PV) or other areas, including cerebellum, corpus callosum (CC), corticospinal
tracts (CS)). Deep White Matter (DWM) vasogenic edema is seen as an intense and
extensive DWM FLAIR signal alteration. This edema isn’t associated to DWI
changes/ADC restriction due to its extracellular location. This edema can be
associated or not with mass effect depending on the degree of edema and underlying
atrophy of patient’s brain. Edema determines a cortical sulcal effacement, PV
ependima’s swelling with reduction of ventricular volume and intense and hyperintensity
in T2 images. Due to extensive brain swelling, subarachnoidal venular stasis is
appreciable and it is shown as contrast enhancement in cortical sulci – similar
to the one that is found in slightly meningitis.
This pattern changes
during resolution treated escape with progressive reduction of all components
of WM swelling/vasogenic (extracellular) edema until complete disappearance of
signal alteration during follow up. This evolution can reach the complete
resolution of the findings. Typically, underlying atrophy may re-emerge.
Of note, the
improvement of signal alteration starts at the same time of the beginning of
clinical stabilization. This happens in a progressive way but more slowly that
the clinical resolution with a sort of mismatch of clinico-radiological
features.Conclusion
Although HIV-ESC and
HIV-ENC occur in different clinical setting, they may show similar MRI
measures. The low GM volumes in HIV-ESC with a long history of infection may be
the legacy of a previous irreversible neuronal damage.Acknowledgements
No acknowledgement found.References
1. Ferretti F, Gisslen M, Cinque P, Price RW. Cerebrospinal Fluid HIV Escape from Antiretroviral Therapy. Curr HIV/AIDS Rep. 2015;12(2):280-288.
2. Mastrangelo A, Turrini F, de Zan V, Caccia R, Gerevini S, Cinque P. Symptomatic cerebrospinal fluid escape. AIDS. 2019;33 Suppl 2:S159-S169.
3. Huppertz HJ, Wagner J, Weber B, House P, Urbach H. Automated quantitative FLAIR analysis in hippocampal sclerosis. Epilepsy Research. 2011;97(1):146-156.